These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 20045984)
1. Inhibitory effects of Kampo medicine on human UGT2B7 activity. Nakagawa N; Katoh M; Yoshioka Y; Nakajima M; Yokoi T Drug Metab Pharmacokinet; 2009; 24(6):490-9. PubMed ID: 20045984 [TBL] [Abstract][Full Text] [Related]
2. Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity. Katoh M; Yoshioka Y; Nakagawa N; Yokoi T Drug Metab Pharmacokinet; 2009; 24(3):226-34. PubMed ID: 19571434 [TBL] [Abstract][Full Text] [Related]
3. Effects of Kampo extracts on drug metabolism in rat liver microsomes: Rhei Rhizoma extract and Glycyrrhizae Radix extract inhibit drug oxidation. Hasegawa A; Kawaguchi Y; Nakasa H; Nakamura H; Ohmori S; Ishii I; Kitada M Jpn J Pharmacol; 2002 Jun; 89(2):164-70. PubMed ID: 12120759 [TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine. Bélanger AS; Caron P; Harvey M; Zimmerman PA; Mehlotra RK; Guillemette C Drug Metab Dispos; 2009 Sep; 37(9):1793-6. PubMed ID: 19487252 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168 [TBL] [Abstract][Full Text] [Related]
6. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261 [TBL] [Abstract][Full Text] [Related]
7. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine. Sun H; Zhang T; Wu Z; Wu B J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of UDP-glucuronosyltransferase by aglycons of natural glucuronides in kampo medicines using SN-38 as a substrate. Yokoi T; Narita M; Nagai E; Hagiwara H; Aburada M; Kamataki T Jpn J Cancer Res; 1995 Oct; 86(10):985-9. PubMed ID: 7493919 [TBL] [Abstract][Full Text] [Related]
9. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment. Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128 [TBL] [Abstract][Full Text] [Related]
10. Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1. Iijima R; Watanabe T; Ishiuchi K; Matsumoto T; Watanabe J; Makino T J Ethnopharmacol; 2018 Mar; 214():153-159. PubMed ID: 29248449 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode. Takeda S; Kitajima Y; Ishii Y; Nishimura Y; Mackenzie PI; Oguri K; Yamada H Drug Metab Dispos; 2006 Aug; 34(8):1277-82. PubMed ID: 16679387 [TBL] [Abstract][Full Text] [Related]
12. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol. Chen M; LeDuc B; Kerr S; Howe D; Williams DA Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037 [TBL] [Abstract][Full Text] [Related]
13. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents. Abdullah NH; Ismail S Molecules; 2018 Oct; 23(10):. PubMed ID: 30347696 [TBL] [Abstract][Full Text] [Related]
15. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Barbier O; Turgeon D; Girard C; Green MD; Tephly TR; Hum DW; Bélanger A Drug Metab Dispos; 2000 May; 28(5):497-502. PubMed ID: 10772627 [TBL] [Abstract][Full Text] [Related]
16. Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate. Ji JZ; Huang BB; Gu TT; Tai T; Zhou H; Jia YM; Mi QY; Zhang MR; Xie HG Biopharm Drug Dispos; 2018 Feb; 39(2):88-98. PubMed ID: 29240983 [TBL] [Abstract][Full Text] [Related]
17. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes. Mano Y; Usui T; Kamimura H Eur J Clin Pharmacol; 2007 Feb; 63(2):211-6. PubMed ID: 17200831 [TBL] [Abstract][Full Text] [Related]
19. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the glucuronidation of 2-(4-chlorophenyl)- 5-(2-furyl)-4-oxazoleacetic acid (TA-1801A). Kaji H; Kume T Drug Metab Pharmacokinet; 2005 Jun; 20(3):212-8. PubMed ID: 15988124 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of morphine glucuronidation in the liver microsomes of rats and humans by monoterpenoid alcohols. Ishii Y; Iida N; Miyauchi Y; Mackenzie PI; Yamada H Biol Pharm Bull; 2012; 35(10):1811-7. PubMed ID: 22878261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]